Monogram Orthopaedics (NASDAQ:MGRM) Issues Earnings Results

Monogram Orthopaedics (NASDAQ:MGRM) issued its quarterly earnings data on Thursday. The company reported ($0.11) earnings per share for the quarter, missing the consensus estimate of ($0.09) by ($0.02), Zacks reports. During the same quarter in the prior year, the company earned ($0.27) EPS.

Monogram Orthopaedics Price Performance

Monogram Orthopaedics stock traded up $0.03 during trading hours on Friday, hitting $2.82. The company had a trading volume of 62,426 shares, compared to its average volume of 122,295. The firm has a 50-day moving average of $2.27 and a 200 day moving average of $2.38. The firm has a market cap of $89.31 million, a PE ratio of -5.64 and a beta of 2.21. Monogram Orthopaedics has a one year low of $1.53 and a one year high of $5.15.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.